Decline speeding up, week 14 of the Sell signal
Evommune sinks 18.5% to a new 30-week low as the daily RSI drops to 19
Our view last week
Evommune drops another 12%, its 6th straight losing week: sellers took 85% of the weekly bar, up from 68% a week earlier, and distribution is intensifying. The price action on Evommune stock stays bearish, with money flow still sliding and a rising ADX showing the downtrend gaining conviction. The short is now more than 34% in profit, with price hugging its 30-day lows in the 8.25 area.
This week's summary
Evommune sheds another 18.5% and prints a new 30-week low, in the 6.7 area: after last week's 12% drop the decline is lengthening its stride, and this is the 7th straight losing week. Price action on Evommune stock stays bearish, with money flow weakening further and the ADX rising for 5 weeks. The short is now more than 46% in profit, while a daily RSI at 19 flags an oversold reading from which, on a name this volatile, a technical bounce can come fast.
IQS Phase
74
in tension
Signal Strength
100
downtrend making lower lows, pace holding
Sizing
STANDARD
Ranking
#2 / 175
US stocks
Trade P&L %
+46.60%
from signal to date, no stop loss
Evommune (EVMN) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 2nd among the 175 sell signals for US stocks in our ranking, with a signal strength of 100 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -2.65% · monthly -3.91%
EVMN belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content